Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model [Structural Heart Disease]

Conclusions— In a large, multicenter, non-US cohort of patients with transcatheter aortic valve replacement, the validation of the TVT registry model demonstrated moderate discrimination and good calibration for the prediction of in-hospital and 30-day mortality. As a result, the TVT registry model should be considered an alternative to the Society of Thoracic Surgeons Predicted Risk of Mortality score for decision making and assessment of early outcome in patients eligible for transcatheter aortic valve replacement.

http://circinterventions.ahajournals.org/cgi/content/short/10/11/e005481?rss=1

Source: Circulation: Cardiovascular Interventions - November 10, 2017 Category: Cardiology Authors: Pilgrim, T., Franzone, A., Stortecky, S., Nietlispach, F., Haynes, A. G., Tueller, D., Toggweiler, S., Muller, O., Ferrari, E., Noble, S., Maisano, F., Jeger, R., Roffi, M., Grunenfelder, J., Huber, C., Wenaweser, P., Windecker, S. Tags: Valvular Heart Disease, Aortic Valve Replacement/Transcatheter Aortic Valve Implantation, Mortality/Survival Structural Heart Disease Source Type: research